Kestra Advisory Services’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,249
Closed -$17.3K 2346
2022
Q4
$17.3K Sell
26,249
-5,046
-16% -$2.66K ﹤0.01% 2221
2022
Q3
$14K Buy
31,295
+7,030
+29% +$3.65K ﹤0.01% 2076
2022
Q2
$12K Buy
+24,265
New +$11.9K ﹤0.01% 2104
2022
Q1
Sell
-24,232
Closed -$15K 2153
2021
Q4
$15K Buy
+24,232
New +$27.3K ﹤0.01% 1999
2021
Q3
Sell
-27,729
Closed -$47K 2199
2021
Q2
$47K Buy
+27,729
New +$47.8K ﹤0.01% 1980
2021
Q1
Sell
-21,827
Closed -$37K 2095
2020
Q4
$37K Buy
21,827
+1,996
+10% +$1.98K ﹤0.01% 1827
2020
Q3
$15K Buy
+19,831
New +$15.7K ﹤0.01% 1406

Other funds holding TMDI

Kestra Advisory Services's TMDI Position: Q1 2023 in Review

Kestra Advisory Services sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 26,249 shares — an estimated $17.3K sold.

Kestra Advisory Services first reported a position in TMDI in Q3 2020 and held it in 7 quarters. The position peaked at $47K in Q2 2021. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • Kestra Advisory Services reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Kestra Advisory Services sold 26,249 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $17.3K.
  • Kestra Advisory Services first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2020 and held it in 7 quarters.
  • Kestra Advisory Services's Titan Medical Inc. Ordinary Shares position peaked at $47K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Kestra Advisory Services's 13F filing for Q1 2023, filed 12 May 2023.